top of page
Blog
Tahoe Bio Raised $30M To Build AI Models Of Living Cells
The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them to find new cures for cancer.
Aug 111 min read
Gordon To Leave Oxford Nanopore
Gordon is stepping down as CEO of Oxford Nanopore and is set to leave the post before the end of 2026.
Aug 111 min read
10x Genomics Acquires Scale Biosciences to Boost Single-Cell Capabilities
10x Genomics is acquiring Scale Biosciences in a $30M cash-and-stock deal plus milestones.
Aug 71 min read
"Longcell" Enables scRNA-seq Innovation
Long-read sequencing boosts alternative splicing analysis but faces technical and computational barriers in single-cell and spatial...
Jul 191 min read
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
The last August 8th, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the Center for Pediatric CRISPR Cures (Center).
Jul 151 min read
Long Read Sequencing improves the diagnosis of rare diseases
A new study published in The American Journal of Human Genetics evaluated the use of long-read sequencing (LRS) with nanopore technology to diagnose rare genetic diseases
Feb 211 min read
bottom of page